Bard Receives Approval for Advanced Ablation Catheter; Stinger S Ablation Catheter Offers Superior Catheter Placement and Control.Business Editors and Medical/Health Writers MURRAY HILL, N.J.--(BUSINESS WIRE)--June 28, 2001 C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE-BCR) today announced it had received Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) approval to market the Bard Stinger(TM) S ablation catheter for the treatment of cardiac arrhythmias. The new ablation catheter offers a firmer distal tip than the standard Stinger ablation catheter, resulting in greater column strength and catheter tissue contact. The feature provides unique characteristics that allow the electrophysiologist to treat arrhythmias in various cardiac anatomies presented by the patient. "The approval of our Stinger(TM) S ablation catheter underscores Bard's overall leadership in the electrophysiology market," said Bard chairman and chief executive officer, William H. Longfield, "and demonstrates our proven ability to develop new and innovative products to diagnose and treat abnormalities of the heart." Ablation catheters are used to eliminate short circuits in the heart tissue that cause the heart to beat rapidly. This is accomplished by applying radiofrequency (RF) energy, the most widely accepted energy source used for cardiac ablation, through the catheter, directly to the tissue of the heart to destroy the circuit(s) causing the problem. After a successful RF ablation procedure, patients are usually discharged from the hospital either the same day or the next day and will generally resume normal work and physical activity without any restrictions. The current global market is estimated to be in excess of $100 million. A unique combination of technology, comfort and functionality, the Stinger, Stinger M and Stinger S ablation catheters provide features and capabilities that enhance controlled endocardial endocardial /en·do·car·di·al/ (-kahr´de-al) 1. situated or occurring within the heart. 2. pertaining to the endocardium. endocardial 1. situated or occurring within the heart. 2. ablation. Since pioneering clinical electrophysiology with the first His bundle His bundle n. See bundle of His. recordings (electrical recordings taken from inside the heart) taken more than 30 years ago, Bard has been providing reliable, innovative products to the EP marketplace. Today, Bard Electrophysiology is the only company offering a full line of diagnostic and therapeutic catheters and a computerized EP recording system. C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey
Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. , oncology and surgical specialty surgical specialty A specialty of health care in which interventions constitute a significant component of Pt management Examples OB/GYN, ophthalmology, ENT, surgery–cardiothoracic, colorectal, general, neurologic, orthopedic, plastic, urology. products. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion